BUCOLO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 13.901
EU - Europa 7.908
AS - Asia 7.333
SA - Sud America 1.331
AF - Africa 876
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 10
Totale 31.376
Nazione #
US - Stati Uniti d'America 13.388
SG - Singapore 3.691
IT - Italia 2.330
RU - Federazione Russa 2.208
CN - Cina 1.972
BR - Brasile 1.119
IE - Irlanda 1.032
UA - Ucraina 863
VN - Vietnam 593
CI - Costa d'Avorio 405
CA - Canada 389
FR - Francia 359
DE - Germania 275
KR - Corea 232
GB - Regno Unito 178
NG - Nigeria 161
IN - India 146
SN - Senegal 145
BD - Bangladesh 140
SE - Svezia 132
FI - Finlandia 105
HK - Hong Kong 89
PL - Polonia 77
AR - Argentina 75
MX - Messico 75
NL - Olanda 67
ES - Italia 65
JP - Giappone 64
IQ - Iraq 59
ZA - Sudafrica 52
ID - Indonesia 51
CH - Svizzera 47
TR - Turchia 47
UZ - Uzbekistan 39
PK - Pakistan 33
EC - Ecuador 32
BE - Belgio 28
CO - Colombia 28
MA - Marocco 27
KE - Kenya 23
GR - Grecia 21
LT - Lituania 21
LB - Libano 19
VE - Venezuela 19
AE - Emirati Arabi Uniti 18
AT - Austria 18
BJ - Benin 16
CL - Cile 16
JO - Giordania 15
SA - Arabia Saudita 15
TN - Tunisia 15
AU - Australia 14
PY - Paraguay 14
IR - Iran 12
HR - Croazia 11
PH - Filippine 11
UY - Uruguay 11
CZ - Repubblica Ceca 10
JM - Giamaica 10
PE - Perù 10
RO - Romania 10
EG - Egitto 9
EU - Europa 9
AZ - Azerbaigian 8
DZ - Algeria 8
HN - Honduras 8
MY - Malesia 8
NP - Nepal 8
IL - Israele 7
SY - Repubblica araba siriana 7
DK - Danimarca 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
CR - Costa Rica 5
KZ - Kazakistan 5
RS - Serbia 5
SV - El Salvador 5
CY - Cipro 4
ET - Etiopia 4
HU - Ungheria 4
KG - Kirghizistan 4
NI - Nicaragua 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
GD - Grenada 3
GT - Guatemala 3
MD - Moldavia 3
MK - Macedonia 3
MN - Mongolia 3
TW - Taiwan 3
BB - Barbados 2
BH - Bahrain 2
BS - Bahamas 2
CG - Congo 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
Totale 31.335
Città #
Dallas 2.119
Singapore 2.114
Santa Clara 1.562
Chandler 1.160
Dublin 1.025
San Jose 974
Moscow 905
Jacksonville 865
Ashburn 720
Catania 634
Chicago 547
Boardman 442
Abidjan 405
Hefei 379
Nanjing 285
Lauterbourg 283
Beijing 280
Lawrence 276
Cambridge 270
Andover 268
Toronto 236
Los Angeles 228
Seoul 228
Houston 227
Ho Chi Minh City 199
New York 154
Dakar 145
Des Moines 144
Hanoi 137
Council Bluffs 134
San Mateo 126
Wilmington 120
São Paulo 101
Civitanova Marche 100
Buffalo 95
Rome 87
Grafing 82
Hong Kong 79
Florence 78
Palermo 78
Nanchang 76
Lagos 75
Orem 75
Abuja 71
Shenyang 69
Ottawa 68
Saint Petersburg 66
The Dalles 62
Hebei 61
Messina 56
Columbus 54
Jiaxing 54
Warsaw 54
Bremen 53
Brooklyn 53
Tokyo 53
Rio de Janeiro 49
Milan 48
Changsha 47
Tianjin 47
Lappeenranta 46
Montreal 46
Seattle 40
Munich 38
Denver 37
Naples 36
Phoenix 36
Aci Catena 34
Atlanta 34
Belo Horizonte 34
London 34
San Francisco 33
Johannesburg 31
Redwood City 31
Helsinki 29
Amsterdam 28
Washington 28
Dong Ket 27
Falls Church 27
Stockholm 27
Mexico City 26
Baghdad 25
Dearborn 25
Pune 25
Curitiba 24
Hangzhou 24
Belpasso 23
Redondo Beach 23
Tashkent 23
Brussels 22
Turku 22
Brasília 21
Jakarta 21
Ningbo 20
Pozzallo 20
Guangzhou 19
Haiphong 19
Manchester 19
Boston 18
Jinan 18
Totale 20.595
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 297
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 280
Current drug treatments targeting dopamine D3 receptor 243
Dopaminergic-GABAergic interplay and alcohol binge drinking 236
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 224
Cholesterol metabolites modulate ionotropic P2X4 and P2X7 receptor current in microglia cells 210
NAP modulates hyperglycemic–inflammatory event of diabetic retina by counteracting outer blood retinal barrier damage 210
Antioxidant and osmoprotecting activity of taurine in dry eye models 195
A novel adamantane derivative attenuates retinal ischemia-reperfusion damage in the rat retina through sigma1 receptors 190
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 189
Carnosine decreases PMA-induced oxidative stress and inflammation in murine macrophages 188
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 187
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 186
Curcumin prevents high glucose damage in retinal pigment epithelial cells through ERK1/2-mediated activation of the Nrf2/HO-1 pathway 185
Caffeine Protects Against Retinal Inflammation 184
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 183
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway Inhibition 182
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 182
Purinergic ionotropic P2X7 and metabotropic glutamate mGlu5 receptors crosstalk influences pro-inflammatory conditions in microglia 180
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 178
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 175
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 171
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 165
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 165
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 164
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 164
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 163
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 160
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 159
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 158
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 157
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 156
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 156
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 152
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 151
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 151
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 150
Efficacy and Safety of Subthreshold Micropulse Yellow Laser for Persistent Diabetic Macular Edema After Vitrectomy: A Pilot Study 148
LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes 147
Epiretinal Membrane Vitrectomy With and Without Intraoperative Intravitreal Dexamethasone Implant: A Systematic Review With Meta-Analysis 146
Fluoxetine Protects Retinal Ischemic Damage in Mice 141
Prognostic significance of deregulated microRNAs in uveal melanomas 141
Retinal Protection of New Nutraceutical Formulation 140
Corneal wound healing and nerve regeneration by novel ophthalmic formulations based on cross-linked sodium hyaluronate, taurine, vitamin B6, and vitamin B12 140
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 140
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 140
Carnosol attenuates high glucose damage in human retinal endothelial cells through regulation of ERK/Nrf2/HO-1 pathway 139
Controversies in Glaucoma: Current Medical Treatment and Drug Development 139
A prolonged release polymeric nanocarrier for ocular administration 139
Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies 138
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 137
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 137
Carnosine Counteracts the Molecular Alterations Aβ Oligomers-Induced in Human Retinal Pigment Epithelial Cells 135
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 135
Influence of trace elements on neurodegenerative diseases of the eye—the glaucoma model 135
Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage 135
Acidic mammalian chitinase in dry eye conditions 132
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 132
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 131
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 131
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 131
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 131
Omega-3 Fatty Acids and Depression: Scientific Evidence and Biological Mechanisms 130
Modulation of pro-oxidant and pro-inflammatory activities of m1 macrophages by the natural dipeptide carnosine 130
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 129
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 127
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 127
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 127
Retinal protection and distribution of curcumin in vitro and in vivo 126
"In Vivo" Evaluation of Biocompatibility and Biodegradation of Different Hyaluronan Derivatives Intravitreal Implants with Ultrasound Biomicroscopy. 125
Novel therapeutics in glaucoma management 125
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 125
Ocular pharmacological profile of hydrocortisone in dry eye disease 125
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 123
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 122
Carnosine protects macrophages against the toxicity of aβ1-42 oligomers by decreasing oxidative stress 122
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 121
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 120
Corneal protective effects of a new ophthalmic formulation based on vitamin B12 and sodium hyaluronate 119
P2X7 receptor antagonism: implications in diabetic retinopathy 119
Acidic Mammalian chitinase and the eye: implications for ocular inflammatory diseases. 119
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 118
Drug-Repurposing Strategy for Dimethyl Fumarate 117
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 117
Resolvin D1 attenuates the inflammatory process in mouse model of LPS-induced keratitis 117
Do extracellular RNAs provide insight into uveal melanoma biology? 117
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 116
PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina 115
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 115
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 115
From Molecular Biology to Novel Immunotherapies and Nanomedicine in Uveal Melanoma 114
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 114
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 114
The immune system on the TRAIL of Alzheimer’s disease 114
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 113
From Preformulative Design to in Vivo Tests: A Complex Path of Requisites and Studies for Nanoparticle Ocular Application. Part 2: In Vitro, Ex Vivo, and In Vivo Studies 111
Integrating network pharmacology: The next-generation approach in ocular drug discovery 111
Davunetide (NAP) Protects the Retina Against Early Diabetic Injury by Reducing Apoptotic Death 111
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 110
Effects of Cloricromene, a Coumarin Derivative, on Rabbit Dry Eye Model 109
Totale 14.795
Categoria #
all - tutte 105.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 0 0 94
2021/20222.151 242 278 44 32 305 58 318 92 210 38 71 463
2022/20233.666 317 175 54 374 395 598 37 617 858 46 131 64
2023/20241.588 117 230 87 106 83 326 27 118 12 25 276 181
2024/20256.437 81 997 324 319 1.341 725 324 274 552 573 464 463
2025/202613.932 811 735 2.465 856 2.030 2.575 1.604 342 707 773 715 319
Totale 31.960